by vdc | Mar 26, 2012 | General
Last year witnessed the lowest amount of biotech seed investment activity in 15 years, according to Xconomy, even though investments surged towards the end of the year. We analyzed information from OnBioVC to figure out how Massachusetts fared compared to other...
by vdc | Feb 7, 2012 | General
Most startup accelerators feature an impressive roster of mentors “ready to help you take your company to the next level.” With the explosion of accelerators, there’s actually an “arm’s race” to sign them up. But how do you know if...
by vdc | Jun 3, 2011 | General
By Rodney H. Brown, Mass High Tech Novophage Inc., a startup that was known until March as Novophage Therapeutics Inc., has taken in $5.75 million in its first institutional funding round. The deal also brings on Micah Rosenbloom, co-founder of Bronte Technologies, as...
by vdc | Oct 28, 2010 | Incubators
With a proof of concept in hand, startup NobleGen Biosciences is setting up at the VDC to develop and commercialize a single-molecule sequencing technology that uses arrays of solid-state nanopores and optical detection. The method comes from the lab of Amit Meller at...
by vdc | Oct 25, 2010 | General, Tech transfer
Susan Windham-Bannister, Massachusetts Life Sciences Center, and Dustin Armstrong, 4s3 Bioscience 4s3 Bioscience, Inc., an early-stage Massachusetts biotherapeutics company, is moving to the Venture Development Center, its first formal location. The company was...
